Publications by authors named "Nichole Davey"
Article Synopsis
- Lupus erythematosus (LE) is an autoimmune disease that can manifest as systemic lupus erythematosus (SLE) or cutaneous lupus erythematosus (CLE), with no FDA-approved treatment specifically for CLE; it is often treated similarly to SLE.
- Two cases of SLE patients with severe skin issues unresponsive to standard treatments like hydroxychloroquine and belimumab were successfully treated with anifrolumab, demonstrating significant skin improvements.
- Anifrolumab, an FDA-approved medication for moderate to severe SLE since August 2021, may be beneficial for early treatment of severe cutaneous manifestations in lupus patients
Rheumatoid arthritis is a multisystem autoimmune inflammatory disease that typically presents as a case of arthritis that can later progress to involve multiple organs. Interstitial lung disease is one of the many extra-articular manifestations of rheumatoid arthritis. We discuss a case of rheumatoid arthritis that presented with interstitial lung disease prior to the development of arthritis along with the discussion of novel anti-carbamylated protein antibody as a serological marker for the diagnosis of seronegative rheumatoid arthritis.
View Article and Find Full Text PDF